Literature DB >> 3570469

Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens.

D A Cohn, G Schiffman.   

Abstract

Antibody responses to two structurally different pneumococcal polysaccharides, type 3 (SIII) and type 14 (SXIV), were examined in intact and splenectomized (Sx) A/J mice to determine whether the role of the spleen in immune responses to these antigens varies with respect to the dosage, the antigenic structure, or the interval between immunization and assay. Antibody responses to SIII and SXIV, measured over a 4-week period by radioimmunoassay, differed in antigenic load requirements, kinetics, and extent of dependence upon the spleen. Intact mice given 50 or 100 ng of SIII produced peak antibody responses on day 5, which tapered off by days 14 and 21. Intact mice given SXIV required doses 100 times greater than those of SIII to stimulate high levels of antibody response; antibody responses increased on day 5 and remained elevated through day 28. In Sx mice given 50 or 100 ng of SIII, the peak antibody response on day 5 was obliterated, but extrasplenic sources produced low levels of antibody which peaked by day 14. In Sx mice given SXIV, all anti-SXIV responses were abrogated regardless of the dose or day of assay. Differences between the anti-SIII and anti-SXIV responses in dependence upon the spleen were probably due to structural differences between the two antigens and to the localization of each to different sites in the reticuloendothelial system. These results attest to the importance of the spleen in antibacterial resistance. They show that, even in the presence of extrasplenic antibody synthesis, the spleen is required for early antibody production, the timing of which is critical for the effective clearance of bacteria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570469      PMCID: PMC260523          DOI: 10.1128/iai.55.6.1375-1380.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

2.  Effect of splenectomy on the expression of regulatory T cell activity.

Authors:  D F Amsbaugh; B Prescott; P J Baker
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

Review 3.  The role of the spleen in resistance to infection.

Authors:  J F Bohnsack; E J Brown
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

4.  Sensitivity to androgen. A possible factor in sex differences in the immune response.

Authors:  D A Cohn
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

5.  A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques.

Authors:  G Schiffman; R M Douglas; M J Bonner; M Robbins; R Austrian
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages.

Authors:  J H Humphrey; D Grennan
Journal:  Eur J Immunol       Date:  1981-03       Impact factor: 5.532

7.  Immune response after splenectomy.

Authors:  J L Sullivan; H D Ochs; G Schiffman; M R Hammerschlag; J Miser; E Vichinsky; R J Wedgwood
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

8.  Tolerogenic or immunogenic activity of hapten-conjugated polysaccharides correlated with cellular localization.

Authors:  J H Humphrey
Journal:  Eur J Immunol       Date:  1981-03       Impact factor: 5.532

9.  A gene of the immunoglobulin H-chain cluster controls the murine antibody response to pneumococcal polysaccharide type 14.

Authors:  O Mäkelä; V J Pasanen; H Sarvas; M Lehtonen
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

10.  Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

Authors:  D F Amsbaugh; C T Hansen; B Prescott; P W Stashak; D R Barthold; P J Baker
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.

Authors:  Henry E Rice; Keith T Oldham; Cheryl A Hillery; Michael A Skinner; Sara M O'Hara; Russell E Ware
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

Review 3.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

4.  In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle.

Authors:  G Harms; M J Hardonk; W Timens
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig.

Authors:  F P Nijkamp; P Braquet; G C Kessels; D van Heuven-Nolsen
Journal:  Agents Actions       Date:  1989-01

6.  The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria.

Authors:  R J Holdsworth; H McKenzie; D Parratt; A D Irving; A Cuschieri
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

7.  Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes.

Authors:  R Leemans; W Manson; J A Snijder; J W Smit; H J Klasen; T H The; W Timens
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

8.  Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.

Authors:  W Timens; R Leemans
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

9.  SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.

Authors:  I S Aaberge; T E Michaelsen; A K Rolstad; E C Groeng; P Solberg; M Løvik
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Minimal role for the spleen in antibody responses of C57BR/cdj mice to pneumococcal polysaccharide antigens.

Authors:  D A Cohn; G Schiffman
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.